What is the Impact Factor of Cancer Biology & Medicine Journal?
Cancer Biology & Medicine is a peer-reviewed open access journal that covers research on cancer-related subjects, including basic and clinical research, translational research, epidemiology, and prevention. It is a bimonthly publication that is indexed in numerous databases, including the National Library of Medicine's PubMed, Scopus, and EMBASE. The journal's impact factor is an important metric that measures the average number of times an article in the journal is cited within a given time period.
What is the current Impact Factor?
The current Impact Factor of Cancer Biology & Medicine, according to the 2020 Journal Citation Reports, is 3.862. This is a significant increase from the previous year's impact factor of 2.767. It is important to note that the impact factor is not the only measure of a journal's quality, as it does not take into account the quality or importance of individual articles. Nevertheless, a higher impact factor is generally considered to be indicative of a journal's increasing prestige in the scientific community.
What were the past Impact Factors?
Over the years, Cancer Biology & Medicine's impact factor has fluctuated, ranging from a low of 1.608 in 2011 to a high of 3.862 in 2020. Below is a table showing the journal's impact factor for the past 5 years.
| Year | Impact Factor |
|---|---|
| 2016 | 3.393 |
| 2017 | 2.549 |
| 2018 | 2.547 |
| 2019 | 2.767 |
| 2020 | 3.862 |
Despite some fluctuations, it is clear that Cancer Biology & Medicine's impact factor has increased significantly over the past few years, indicating the journal's growing success.
Why is Impact Factor important?
Impact factor, despite its limitations, is an important metric for journals and researchers. It allows journals to showcase their reputation and impact in the scientific community, which can attract high-quality publications and submissions. Researchers also consider impact factor when selecting which journals to submit their research to, as publishing in high-impact journals can increase their visibility and status in the scientific community. However, it is important to remember that impact factor should not be the sole criterion for assessing a journal's quality, importance or relevance of individual articles.
Conclusion
Cancer Biology & Medicine's steadily increasing impact factor is a testament to the quality of the journal's research, which covers a broad spectrum of cancer-related subjects. As the scientific community continues to prioritize cancer research, it is likely that the impact factor of Cancer Biology & Medicine will continue to rise, making it a leading publication in the field.
